This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Texas System. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Christopher G. Wood: Innovator in Renal Cell Carcinoma Research
Introduction
Christopher G. Wood is a notable inventor based in Pearland, Texas. He has made significant contributions to the field of medical research, particularly in the diagnosis and treatment of renal cell carcinoma. His innovative work has the potential to improve patient outcomes and advance cancer therapy.
Latest Patents
Christopher G. Wood holds a patent for "Methods for detecting, diagnosing and treating human renal cell carcinoma." This patent focuses on gene expression profiling and hierarchical clustering analysis, which can readily identify differential gene expressions in normal renal epithelial cells and renal cell carcinomas. The genes identified through this analysis are crucial for diagnosis, prognosis, and the development of targeted therapies for the prevention and treatment of conventional renal cell carcinoma. He has 1 patent to his name.
Career Highlights
Christopher is affiliated with the University of Texas System, where he continues to engage in groundbreaking research. His work is instrumental in bridging the gap between laboratory findings and clinical applications, ultimately aiming to enhance the quality of life for patients suffering from renal cell carcinoma.
Collaborations
He has collaborated with esteemed colleagues such as John A. Copland, III, and Bruce A. Luxon. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of cancer research.
Conclusion
Christopher G. Wood's contributions to renal cell carcinoma research exemplify the impact of innovative thinking in medicine. His work not only advances scientific knowledge but also holds promise for improving patient care in oncology.